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Abstract
For a better interpretation of variants, evidence-based databases, such as ClinVar, compile data on the presumed rela-
tionships between variants and phenotypes. In this study, we aimed to analyze the pattern of sequencing depth in vari-
ants from whole-exome sequencing data in the 1000 Genomes project phase 3, focusing on the variants present in the
ClinVar database that were predicted to affect protein-coding regions. We demonstrate that the distribution of the se-
quencing depth varies across different sequencing centers (pair-wise comparison, p < 0.001). Most importantly, we
found that the distribution pattern of sequencing depth is specific to each facility, making it possible to correctly assign
96.9% of the samples to their sequencing center. Thus, indicating the presence of a systematic bias, related to the
methods used in the different facilities, which generates significant variations in breadth and depth in whole-exome se-
quencing data in clinically relevant regions. Our results show that methodological differences, leading to significant het-
erogeneity in sequencing depth, may potentially influence the accuracy of genetic diagnosis. Furthermore, our findings
highlight how it is still challenging to integrate results from different sequencing centers, which may also have an impact
on genomic research.
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Introduction
Whole exome sequencing (WES) has emerged as a
powerful tool in genomic medicine as it provides the possibil-
ity of interrogating the genome in its most interpretable por-
tion (Coffey et al., 2011; Mahon, 2016). This strategy has
identified causal variants in several Mendelian diseases with a
high success rate (Gilissen et al., 2012; Shamseldin et al.,
2017). Therefore, the use of WES has proven to add relevant
diagnostic information, and it is currently widely used in med-
ical practice (Linderman et al., 2014; Suwinski et al., 2019;
Ulintz et al., 2019). However, several methodological issues
can affect the results obtained by WES and may influence its
interpretation (Sulonen et al., 2011; Hardwick et al., 2017).
The capture experiment, followed by the enrichment
phase, is a crucial step to ensure success in WES since it is
essential to determine reads uniformity, depth, and overall
quality of sequencing (Chilamakuri et al., 2014; Wang et al.,
2017). One of several parameters used for quality control on
massively parallel DNA sequencing experiments is the
depth of coverage, which refers to the average number of se-
quenced and adequately aligned bases or reads to a specific
genomic position or region (Elmas et al., 2018). Its expected
value is one of the first parameters to be estimated in the
study design of a given sequencing experiment (Sims et al.,
2014). In WES, the depth varies greatly, so that even when
the expected average depth is high, the capture of some re-
gions may still be problematic, leading to an uneven distri-
bution of sequencing depth (Lelieveld et al., 2015). It is
well-known that the results obtained from massively parallel
DNA sequencing technologies may suffer some biases due
to the experimental design, sample selection, sequencing
strategies, and variant calling methods (Asan et al., 2011;
Hwang et al., 2016; Meienberg et al., 2016; Van Allen et al.,
2016). In this context, we aimed to analyze the pattern of se-
quencing depth in variants from WES data in the 1000
Genomes project phase 3, focusing on the variants present in
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the ClinVar database that were predicted to affect protein-
coding regions.
Materials and Methods
We used the public binary alignment map files (BAM)
available from the 1000 Genomes Project Consortium FTP
web page to calculate the depth of sequencing variations
from ClinVar entries in 1,112 WES samples from sequenc-
ing phase 3 (Table S1). We guarantee the integrity of the an-
alyzed BAM files by automatically generating and checking
the MD5 code of each downloaded file by implementing an
automatic script. If there were any discrepancies between the
MD5 codes provided by the 1000 Genomes Project and the
one obtained by us, we performed the download once again.
The samples were all sequenced in an Illumina HiSeq 2000
with a paired-end sequencing reaction in four different se-
quencing facilities listed below. Each center participating in
the consortium applied a different WES capture methodol-
ogy: the Baylor College of Medicine (BCM) applied a cus-
tomized array HSGC VCRome, the Broad Institute (BI) used
Agilent SureSelect All Exon v2, the Beijing Genomics Insti-
tute (BGI) used NimbleGenSeqCap EZ Exome v2, and the
Washington University Genome Center (WUGC) used
NimbleGenSeqCap EZ Exome v3.
We extracted 282,453 variants from ClinVar (built
20170801, GRCh37.p13) (Landrum et al., 2018) and per-
formed variant annotation using the Ensembl Variant Effect
Predictor (VEP version 84) using the default parameters
(McLaren et al., 2016). Overall, 4,543 variants were classi-
fied as exonic in the autosome chromosomes and had a pre-
dicted impact on mRNA and protein structure and function
(121 were classified as high, 2,166 moderate, 1,641 low, and
615 as a modifier). We provide the variant calling file con-
taining these targets as File S2. We used “samtools depth”
(version 1.3.1) to estimate the base-by-base depth of the
4,543 selected variants for each of the BAM files, accepting
reads with sequencing and mapping quality greater than 30
(99.9% reliability) (Li et al., 2009; Li, 2011). We then per-
formed the merging of each of the BAM files with the cover-
age of our ClinVar targets.
We conducted all further analyses using the R statisti-
cal environment (version 3.3.2) (R Core Team, 2014). First,
we tested the assumption of no difference in the pattern of
sequencing depths in each of the four sequencing centers
with a Mann-Whitney-Wilcoxon test with continuity correc-
tion in the normal approximation for the p-value. We also
applied a multidimensional scaling (MDS) method over the
resulting depth in each region and compared the different
groups, addressing the data high-dimensionality issue, and
obtained a low-dimensional representation of the data
(Kruskal and Wish, 1978). We show the results obtained us-
ing R packages to process and generate conventional and
interactive charts (plyr 1.8.4, plotly 4.8.0, ggplot2 3.0.0).
Furthermore, we visually recorded the variation in depth of
sequencing in the different sequencing centers with a
heatmap (heatmaply 0.9.1) of the 450 variants, which pre-
sented the higher variance across samples. We apply a
method of clustering to this high variability subset of targets
by using the k-means algorithm, considering a total of 5
groups (Macqueen, 1967).
Results
The average sequencing depth from the selected 4,543
variants from ClinVar differed significantly among the se-
quencing centers (pairwise comparisons with Mann-
Whitney-Wilcoxon test, p < 0.001), with an average depth of
82.8  67.6 for the BCM, 123.0  85.6 for the BGI, 86.6 
79.2 for the BI, and 49.4  33.8 for the WUGSC (Figure 1A,
File S2).
The multidimensional scaling analysis corroborates
that the pattern of sequencing depth clusters according to
each sequencing center, with 69% of the variance explained
by the first two principal components in the principal com-
ponent analysis (PCA, Figure 1B, File S2). This indicates
that protocol advancement and intrinsic methodological dif-
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Figure 1 - Variation in depth of sequencing in different sequencing centers.
Depth distribution varies significantly (p < 0.001) among samples from the
four sequencing centers included in this study (BCM - Baylor College of
Medicine, BI - Broad Institute, BGI, and WUGC - Washington University
Genome Center). (A) Density distributions for regions from ClinVar with
depth from 0 to 400, with an average of 82.8  67.6 for BCM, 123.0  85.6
for BGI, 86.6  79.2 for BI, and 49.4  33.8 for WUGSC. (B) Principal com-
ponent analysis (PCA) corroborates our findings, with an explained vari-
ance of 69.0% for the first two components. Complete depth distribution
and an interactive 3D version of Figure 1B is available as File S3.
ferences in each of the sequencing centers directly affect the
pattern of the sequencing depth in the set of variants ana-
lyzed. The inconsistency in the depth and breadth of cover-
age across samples introduces a systematic bias in the results
generated by each center. Sequencing depth is a measure-
ment of how many times a certain variant was sequenced
while the breadth is the capability of adequately capturing
and sequencing a given region.
Furthermore, by analyzing the distribution of the se-
quencing depth of the 450 variants with higher variance, we
could correctly assign 96.9% of the samples to their sequenc-
ing center when considering five clusters to the dendrogram
branches depicted in Figure 2 and File S3. This finding also
supports the existence of different coverage patterns for each
sequencing center, evidenced in the individual coverage of
each of the samples considered in these analyses.
Discussion
Understanding how the depth of sequencing varies in
sequencing experiments is essential to find a balance be-
tween the number of reads necessary to answer a genetic
question and the costs and efforts required to do so (Sims et
al., 2014; Meienberg et al., 2015; Lek et al., 2016). The use
of WES over WGS reduces the broad genomic region to be
analyzed, dropping costs and allowing it to be more widely
used in medical practice (Hu et al., 2017; Manrai et al.,
2018; Suwinski et al., 2019). The public availability of data
from large genomic projects performed by worldwide con-
sortia, such as ExAC, ESP, 1000 Genomes Project, UK10K,
and GoNL, is of the utmost importance for both research and
medical applications of these technologies (van Rooij et al.,
2017). However, one should consider the existence of meth-
odological covariates that may introduce potential bias into
the sequencing data. In our case, the possible
false-negatives, which could, for example, mask the allelic
frequency of a given variant returned from a sequencing cen-
ter. Thus, we note the possibility of considering certain vari-
ants as “false-rares,” since their frequency would be dimin-
ished in the variant discovery process (Schaid et al., 2018).
Kong et al. (2018) argue that both researchers and pa-
tients could benefit from clearer methodological specifica-
tions from vendors. We agree and believe that initiatives that
propose the public availability of data should also provide as
many technical informaion as possible. This could help users
to evaluate better any bias related to the technique or meth-
odology used to generate or to interpret the data, which could
lead to erroneous or discordant clinical interpretations, for
example. Here, we focused on variants that are likely to have
clinical significance (comprising of 4,543 variants), since
they were predicted to promote mRNA changes and/or pro-
tein structure and function alterations related to a phenotype
described in ClinVar (File S2). By doing so, we aimed to as-
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Figure 2 - Variation in sequencing depth across sequencing centers and coding impact. Heatmap showing variation in depth across sequencing centers for
the 450 variants with higher variance across samples. Each row represents a sample from one of the sequencing centers (BCM - Baylor College of Medi-
cine, BI - Broad Institute, BGI, and WUGC - Washington University Genome Center). 96.9% of samples are correctly assigned to their sequencing cen-
ters when considering five clusters to the dendrogram branches. The columns represent each one of the variants, with their impact classified as high, mod-
erate, low, or modifier, which is an indicator that the coding impact does not influence the depth of coverage (p > 0.05 for each pair comparisons). An
interactive version of this figure is available as File S4.
sess the potential impact of variability in sequencing depth
on genetic diagnosis performed by WES. This is especially
relevant when a diagnostic test fails to report a variant since
this could indicate either a true negative, when the genomic
position of the variant is adequately captured and sequenced
or a false negative when the variant is not captured or appro-
priately sequenced (Patwardhan et al., 2015; Shigemizu et
al., 2015; Karlsson Linnér et al., 2019).
Our results indicate that the distribution of sequencing
depth varied across different sequencing centers from the
1000 Genomes Project, phase 3 (pairwise comparisons, p <
0.001). Most importantly, we found that there is a pattern of
distribution in sequencing depth, which is specific to each
facility (Figure 1). These findings are evidenced by the clus-
tering of samples by PCA (69% of variance explained) and
clustering of more than 95% of the samples to their sequenc-
ing centers when considering sites with highly variant cover-
age. These findings indicate that these patterns may be re-
lated to the methodologies used by each center. It is certainly
likely that there are specific regions that differentially failed
to generate adequate coverage, either due to design or cap-
ture efficiency (Altmüller et al., 2016; García-García et al.,
2016). That means that a variant could be missed in any spe-
cific patient who was sequenced using a certain methodol-
ogy specific to the sequencing center where the experiment
was conducted, generating a serious problem imposed on
clinical sequencing. One other piece of evidence that corrob-
orates this is the wide standard deviation found for each of
the sequencing facilities, indicating an unspecific capture re-
action. The inconsistency in the breadth and depth across the
targets comprising of the medically relevant variants de-
mands the attention of professionals and patients seeking di-
agnosis by WES. Such an example happens with the estab-
lishment of the expanded or clinical exome capturing kits,
which tend to maximize variant discovery resolution, but
potentializes capture bias as well (Shamseldin et al., 2017;
Suwinski et al., 2019). This finding also raises questions
about the low frequency of a given variant that may be due to
the methodological bias described in this work.
When performing WES, a critical experimental step is
the capture reaction. It is well known that the efficiency of
capture depends on several experimental procedures as well
as on probe design, which may directly affect sequence
depth and uniformity (Do et al., 2012; Chandler et al., 2016).
Therefore, problems in the capturing reaction directly affect
the final experiment results, yielding not only regions with
different average depths but also leading to regions with no
coverage at all (Lionel et al., 2018; Wang et al., 2018). We
demonstrated here that differences, most likely attributed to
the different methods used by the sequencing centers, pro-
ved to play a significant role in determining the distribution
of sequencing depth in WES data from the 1000 Genomes
Project. We understand that the methodological variability
in the 1000 Genome Consortium could be the best way to
achieve a more in-depth and broader variant catalog capable
of establishing the bases to understand population allele fre-
quency; however, it is also important to recognize the limita-
tions imposed by the methods used. This finding represents a
challenge for large or long-term exome sequencing projects
that expect to aggregate advancements in capture techniques
over time (McCarthy and MacArthur, 2017; Sanghvi et al.,
2018). In addition, it poses questions about the
reproducibility of results among different diagnostic labora-
tories performing WES, indicating the need for further dis-
cussion about the use of clear open methods (both from the
wet and dry lab), which could minimize such bias (Eberle et
al., 2017; Haga, 2017; Roy et al., 2018). The proposal of re-
turning information not only on the variants identified but
also about the methods used, including the regions analyzed
and all the characteristics of the sequencing reaction, could
minimize misinterpretation, which directly influences the
accuracy of genetic testing.
Conclusions
Our results indicate that the sequencing depth in WES
varies significantly across different facilities, leading to a
systematic bias, which is most likely introduced by technical
differences. Our findings indicate that the low coverage or
lack of consistency between WES methodologies has direct
clinical applications. It may introduce false-negatives into
experiments performed for diagnostic purposes and results
in variants with a lower frequency than expected. Our results
are not surprising, given that the initial step for a WES exper-
iment is the capture of the target regions to be subsequently
enriched and sequenced and that this step is susceptible to
the effects of many technical factors. Although difficult to
address, the issue of standardized and open methodologies
should be further discussed.
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1A shows a complete distribution of depth of sequencing and
an interactive 3D version of Figure 1B. Better visualized in
Google Chrome.
File S4. Variation in depth across sequencing centers and
coding impact data from Figure 2 (HTML). Heatmap show-
ing the variation of depth across sequencing centers of the
450 variants with higher variance. Each row represents a
sample from one of the sequencing centers (BCM - Baylor
College of Medicine, BI - Broad Institute, BGI, and WUGC -
Washington University Genome Center). The columns rep-
resent each one of the variants, with their impact classified as
high, moderate, low, or modifier. Better visualized in
Google Chrome.
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